Early Post-marketing Study of Daclatasvir (Daklinza) in the Treatment of Chronic Hepatitis C (CHC) in Adults
Clinical trial NCT03181074 · COMPLETED
Trial details
- NCT number
- NCT03181074
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-10-21
- Primary completion
- 2019-08-19
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.